All KIR2DL3 reagents are produced in house and quality controlled, including 3 KIR2DL3 Antibody, 13 KIR2DL3 Gene, 1 KIR2DL3 Lysate, 1 KIR2DL3 Protein, 1 KIR2DL3 qPCR. All KIR2DL3 reagents are ready to use.
Recombinant KIR2DL3 proteins are expressed by HEK293 Cells with fusion tags as C-His.
KIR2DL3antibodies are validated with different applications, which are ELISA.
KIR2DL3cDNA clones are full length sequence confirmed and expression validated. There are 13 kinds of tags for each KIR2DL3 of different species, especially GFP tag, OFP tag, FLAG tag and so on. There are three kinds of vectors for choice, cloning vector, expression vector and lentivrial expression vector.
Killer cell immunoglobulin-like receptor 2DL3, also known as CD158 antigen-like family member B2, KIR-023GB, Killer inhibitory receptor cl 2-3, MHC class I NK cell receptor, NKAT2a, NKAT2b, Natural killer-associated transcript 2, p58 natural killer cell receptor clone CL-6, p58.2 MHC class-I-specific NK receptor, CD158b2 and KIR2DL3, is a single-pass type I membrane protein which belongs to the immunoglobulin superfamily. KIR2DL3 contains 2 Ig-like C2-type (immunoglobulin-like) domains. KIR2DL3 interacts with ARRB2. KIR2DL3 is a receptor on natural killer (NK) cells for HLA-C alleles (HLA-Cw1, HLA-Cw3 and HLA-Cw7). KIR2DL3 inhibits the activity of NK cells thus preventing cell lysis.